Primoris Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.2M Buy
2,666
+2,402
+910% +$2.45M 1.46% 20
2026
Q1
$243K Hold
264
0.17% 83
2025
Q4
$284K Hold
264
0.17% 93
2025
Q3
$201K Buy
264
+3
+1% +$2.23K 0.13% 101
2025
Q2
$203K Buy
+261
New +$203K 0.14% 94

Other funds holding LLY

Primoris Wealth Advisors's LLY Position: Q2 2026 in Review

Primoris Wealth Advisors increased its Eli Lilly (LLY) stake by 910% in Q2 2026, buying an estimated $2.45M and bringing the position to 2,666 shares worth $3.2M. The position accounts for 1.46% of the portfolio, ranked #20.

Primoris Wealth Advisors first reported a position in LLY in Q2 2025 and has held it in 5 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Primoris Wealth Advisors held 2,666 shares of Eli Lilly worth $3.2M as of Q2 2026.
  • Primoris Wealth Advisors bought 2,402 Eli Lilly shares in Q2 2026, an estimated $2.45M.
  • Eli Lilly made up 1.46% of Primoris Wealth Advisors's portfolio in Q2 2026, its #20 holding.
  • Primoris Wealth Advisors first reported a position in Eli Lilly in Q2 2025 and has held it in 5 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Primoris Wealth Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.